Matching targets for selective cancer therapy

被引：96

作者：

Blagosklonny, MV ^{[1
]}

机构：

[1] New York Med Coll, Hawthorne, NY 10532 USA

来源：

DRUG DISCOVERY TODAY | 2003年 / 8卷 / 24期

关键词：

D O I：

10.1016/S1359-6446(03)02806-X

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1104 / 1107

页数：4

共 24 条

[1] Taxanes: Microtubule and Centrosome Targets, and Cell Cycle Dependent Mechanisms of Action [J].

Abal, M. ;

Andreu, J. M. ;

Barasoain, I. .

CURRENT CANCER DRUG TARGETS, 2003, 3 (03) :193-203

[2] Cyclotherapy Protection of Normal Cells and Unshielding of Cancer Cells [J].

Blagosklonny, Mikhail V. ;

Darzynkiewicz, Zbigniew .

CELL CYCLE, 2002, 1 (06) :375-382

[3] A new science-business paradigm in anticancer drug development [J].

Blagosklonny, MV .

TRENDS IN BIOTECHNOLOGY, 2003, 21 (03) :103-106

[4] Why Iressa failed - Toward novel use of kinase inhibitors (outlook) [J].

Blagosklonny, MV ;

Darzynkiewicz, Z .

CANCER BIOLOGY & THERAPY, 2003, 2 (02) :137-140

[5] Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs [J].

Blagosklonny, MV .

ONCOGENE, 2002, 21 (41) :6249-6254

[6] Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs [J].

Blagosklonny, MV .

LEUKEMIA, 2002, 16 (04) :455-462

[7] Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells [J].

Blagosklonny, MV .

LEUKEMIA, 2001, 15 (06) :936-941

[8] Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].

Bunz, F ;

Dutriaux, A ;

Lengauer, C ;

Waldman, T ;

Zhou, S ;

Brown, JP ;

Sedivy, JM ;

Kinzler, KW ;

Vogelstein, B .

SCIENCE, 1998, 282 (5393) :1497-1501

[9] Therapeutic Exploitation of Checkpoint Defects in Cancer Cells Lacking p53 Function [J].

Dixon, Helen ;

Norbury, Chris J. .

CELL CYCLE, 2002, 1 (06) :362-368

[10] Perspectives on the development of a molecularly targeted agent [J].

Druker, BJ .

CANCER CELL, 2002, 1 (01) :31-36

← 1 2 3 →